We are live on
!
Find out more
A
AustralianSuper Portfolio holdings
AUM
$23.1B
1-Year Est. Return
49.74%
This Fund
S&P 500
This Quarter
Est. Return
-15.67%
1 Year Est. Return
+49.74%
3 Year Est. Return
+142.09%
5 Year Est. Return
+159.34%
10 Year Est. Return
–
AUM
$16.2B
AUM Growth
-$2.2B
(-12%)
Cap. Flow
+$736M
Cap. Flow
% of AUM
4.54%
Top 10 Holdings %
Top 10 Hldgs %
35.09%
Holding
198
New
16
Increased
100
Reduced
56
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$255M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$202M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$174M |
| 4 |
Apple
AAPL
|
+$167M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$171M |
| 2 |
Veeva Systems
VEEV
|
+$170M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$169M |
| 4 |
VF Corp
VFC
|
+$123M |
| 5 |
Adobe
ADBE
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 17.3% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 12.99% |
| 5 | Materials | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Imperial Oil
IMO
$63.8B
| $12.4M | 0.08% |
262,992
-41,455
| -14% | -$2.12M |
|
152
Colgate-Palmolive
CL
$71.8B
| $12M | 0.07% |
149,858
-156,969
| -51% | -$12.3M |
|
153
Kinross Gold
KGC
$37.5B
| $12M | 0.07% |
3,374,276
-400,496
| -11% | -$1.94M |
|
154
CF Industries
CF
$20.9B
| $11.7M | 0.07% |
+136,207
| New | +$13.2M |
|
155
Robert Half
RHI
$4.4B
| $11.3M | 0.07% |
150,278
+14,434
| +11% | +$1.37M |
|
156
Teradyne
TER
$52.9B
| $10.8M | 0.07% |
120,157
+19,352
| +19% | +$2.01M |
|
157
Ulta Beauty
ULTA
$23.8B
| $10M | 0.06% |
+26,056
| New | +$10.4M |
|
158
Synchrony
SYF
$26B
| $9.59M | 0.06% |
+347,089
| New | +$12M |
|
159
Cisco
CSCO
$428B
| $9.54M | 0.06% |
223,628
+86,747
| +63% | +$4.15M |
|
160
Teck Resources
TECK
$33.8B
| $9.36M | 0.06% |
+306,257
| New | +$12.1M |
|
161
Jazz Pharmaceuticals
JAZZ
$16.1B
| $8.87M | 0.05% |
56,832
-63,358
| -53% | -$9.75M |
|
|
CTRA
162
DELISTED
Coterra Energy
CTRA
| $8.79M | 0.05% |
340,884
-126,428
| -27% | -$3.83M |
|
163
lululemon athletica
LULU
$13.8B
| $8.42M | 0.05% |
30,892
-53,195
| -63% | -$17M |
|
164
GoDaddy
GDDY
$13.1B
| $8.13M | 0.05% |
+116,864
| New | +$8.88M |
|
165
Chewy
CHWY
$9.81B
| $8.05M | 0.05% |
231,842
+5,981
| +3% | +$192K |
|
166
Universal Health Services
UHS
$9.97B
| $6.51M | 0.04% |
64,667
-61,235
| -49% | -$7.67M |
|
167
TFI International
TFII
$10.9B
| $6.24M | 0.04% |
+77,671
| New | +$6.32M |
|
168
BorgWarner
BWA
$13.4B
| $5.95M | 0.04% |
202,548
-84,676
| -29% | -$2.79M |
|
169
Wayfair
W
$13.3B
| $5.82M | 0.04% |
133,589
-24,711
| -16% | -$1.74M |
|
170
Medtronic
MDT
$119B
| $5.77M | 0.04% |
64,270
-248,354
| -79% | -$25.2M |
|
171
A.O. Smith
AOS
$8.23B
| $5.46M | 0.03% |
99,778
-1,500
| -1% | -$90K |
|
172
FirstService
FSV
$6.24B
| $5.3M | 0.03% |
43,729
-14,309
| -25% | -$1.8M |
|
|
173
Veeva Systems
VEEV
$46B
| $4.06M | 0.03% |
20,492
-924,017
| -98% | -$170M |
|
174
DaVita
DVA
$11.6B
| $3.76M | 0.02% |
+47,055
| New | +$4.76M |
|
175
Shopify
SHOP
$188B
| $1.7M | 0.01% |
54,500
-1,661,110
| -97% | -$70.9M |
|
Similar funds
CLGM
DSA
BBHC
CB
EIM
AustralianSuper's Q2 2022 Portfolio in Review
As of Q2 2022, AustralianSuper held 198 positions worth $16.2B, down 12% from $18.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
AustralianSuper deployed $736M of net new capital in Q2 2022, opening 16 new positions and adding to 100 existing holdings. Its largest new stake was Bio-Rad Laboratories Class A: 387,567 shares worth $192M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Estee Lauder, an estimated $171M trimmed.
- AustralianSuper's largest Q2 2022 buy was Bio-Rad Laboratories Class A: 387,567 shares worth $192M.
- AustralianSuper added most to Intuit in Q2 2022, an estimated $255M increase.
- AustralianSuper's biggest Q2 2022 reduction was Estee Lauder, cutting an estimated $171M.
- AustralianSuper fully exited Goldman Sachs in Q2 2022, selling an estimated $86.5M.
- AustralianSuper's ten largest holdings make up 35% of its $16.2B portfolio in Q2 2022.
- AustralianSuper opened 16 new positions and closed 23 in Q2 2022.
- AustralianSuper's portfolio value fell 12% quarter-over-quarter to $16.2B.
Based on AustralianSuper's 13F filing for Q2 2022, filed 13 Jul 2022.